Replies to post #113479 on Biotech Values

[10nisman]

I agree Teva's tone and substance changed in their recent PR, but the simplest explanation for that is they got a deficiency letter from the FDA. Their statements over time are perfectly consistent with the FDA having at one point told them that their application was doing fine and approval was likely/imminent and then subsequently sending them the deficiency letter.

Teva changed its tone and substance after MNTA's lawsuit and well before the most recent PR. Listen to Bill Marth's presentation at the Goldman Sach's conference vs. his previous presentations.

10nis

[Cactus Quave]

Their [Teva's] statements over time are perfectly consistent with the FDA having at one point told them...

If the FDA has mislead Teva to the point and substantiating the misleading PR from Teva regarding t-enox approval over the last six months, then shame on the FDA. Whatever the case, somebody has been fooling somebody.